Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community‐acquired methicillin‐resistant Staphylococcus aureus

PURPOSE: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed. DATA SOURCES: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966-2006). CONCLUSIONS: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed. IMPLICATIONS FOR PRACTICE: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.